11β-Hydroxysteroid dehydrogenase type 1: a tissue specific regulator of glucocorticoid response
The DOI matches its Crossref record; 398 of the 412 references it cites were found in a registry or an index.
Abstract
11beta-hydroxysteroid dehydrogenase type 1 (11beta-HSD1) interconverts inactive cortisone and active cortisol. Although bidirectional, in vivo it is believed to function as a reductase generating active glucocorticoid at a prereceptor level, enhancing glucocorticoid receptor activation. In this review, we discuss both the genetic and enzymatic characterization of 11beta-HSD1, as well as describing its role in physiology and pathology in a tissue-specific manner. The molecular basis of cortisone reductase deficiency, the putative "11beta-HSD1 knockout state" in humans, has been defined and is caused by intronic mutations in HSD11B1 that decrease gene transcription together with mutations in hexose-6-phosphate dehydrogenase, an endoluminal enzyme that provides reduced nicotinamide-adenine dinucleotide phosphate as cofactor to 11beta-HSD1 to permit reductase activity. We speculate that hexose-6-phosphate dehydrogenase activity and therefore reduced nicotinamide-adenine dinucleotide phosphate supply may be crucial in determining the directionality of 11beta-HSD1 activity. Therapeutic inhibition of 11beta-HSD1 reductase activity in patients with obesity and the metabolic syndrome, as well as in glaucoma and osteoporosis, remains an exciting prospect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cortisone and prednisone are inactive prohormones that must be reduced to cortisol or prednisolone by hepatic 11HSD1 to bind to and activate the glucocorticoid receptor (GR) (45, 587).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [587]
In the citing paper
“other health outcomes associated with better quality of life improved, including sleep apnoea136 and mobility137.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [136]
In the citing paper
“the glucocorticoid sensitivity may be different among the different individuals and among the different tissues in the same individual, due also to polymorphisms of both glucocorticoid receptor (25)(26)(27)(28) and 11-hydroxysteroid-dehydrogenase type 1 genes (29,30).”
From Diagnosis and Treatment of Subclinical Hypercortisolism (2011) · cites this paper as [29]
In the citing paper
“HSD11B2 functions exclusively as an oxidative enzyme, inactivating cortisol to cortisone [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
In the citing paper
“while 17OHP and cortisol can be either 5α- or 5β-reduced, 11-deoxycortisol and cortisone are predominantly 5β-reduced [108].”
From Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: a comprehensive review (2019) · cites this paper as [108]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 1×
“Immunomodulation represents an important facet of glucocorticoid physiology and inflammation therapy and is manifested by the regulation of cytokine production and immune cell function (324).”
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
A transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 1×
“Mice overexpressing 11 -HSD1 under the aP2 promoter have enhanced adipocyte differentiation (as measured by increased fat cell size) as a consequence of increased adipose tissue corticosteroid concentrations (139) (see Section VII.”
Short-chain dehydrogenases/reductases (SDR)
Jörnvall, H., Persson, B., Krook, M., Atrian, S., Gonzalez-Duarte, R., Jeffery, J., & Ghosh, D. (1995) · Biochemistry · doi:10.1021/bi00018a001 · Cited by 1,249 · cited 3×
“Also known as short-chain alcohol dehydrogenases (35) or sec (secondary) alcohol dehydrogenases (36), members of this family were originally classified as having 250–300 residues (classical family) with an N-terminal cofactor-binding domain and a centrally located active site, although some enzymes now have more than…”
Edwards, C. R. W., Burt, D., Mcintyre, M. A., De Kloet, E. R., Stewart, P. M., Brett, L., Sutanto, W. S., & Monder, C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90742-8 · Cited by 1,068
Self-citationCole, T. J., Blendy, J. A., Monaghan, A. P., Krieglstein, K., Schmid, W., Aguzzi, A., Fantuzzi, G., Hummler, E., Unsicker, K., & Schütz, G. (1995) · Genes & Development · doi:10.1101/gad.9.13.1608 · Cited by 946 · cited 1×
“Within the fetal rat lung, corticosteroids increased 11-oxoreductase activity, which in turn resulted in an increase in surfactant synthesis (71), a glucocorticoiddependent process (336) essential for normal lung maturation.”
Impaired Energy Homeostasis in C/EBPα Knockout Mice
Wang, N.-D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R., & Darlington, G. J. (1995) · Science · doi:10.1126/science.7652557 · Cited by 929
Kotelevtsev, Y., Holmes, M. C., Burchell, A., Houston, P. M., Schmoll, D., Jamieson, P., Best, R., Brown, R., Edwards, C. R. W., Seckl, J. R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14924 · Cited by 858
Stewart, P., Valentino, R., Wallace, A. M., Burt, D., Shackleton, C. L., & Edwards, C. W. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91014-2 · Cited by 803
Self-citationANTI-ESCHERICHIA COLI ALPHA-HAEMOLYSIN IN CONTROL AND PATIENT SERA
Emody, L., Batai, I., Kerényi, M., Székely, J., & Polyak, L. (1982) · The Lancet · doi:10.1016/s0140-6736(82)90183-0 · Cited by 800
Research works printed but not linked: 6
- Bush, 1969, 11β-Hydroxysteroid dehydrogenase: contrast between studies in vivo and studies in vitro., Adv Biosci, 3, 23
- Taylor, 1990, Corticosteroid 11-reductase deficiency: steroid studies in a further family, J Clin Invest, 13, P238
- Burtt, 2003, Haplotype-based association studies of HSD11B1 and abdominal obesity, 117
- Bujalska, 2000, Glucocorticoids, 11β-hydroxysteroid dehydrogenase and obesity, 158
- Taylor, 1984, Cortisone reductase deficiency: evidence for a new inborn error in metabolism of adrenal steroids, J Endocrinol, 102, 89
- Savage, 1991, Increased metabolic clearance of cortisol in corticosteroid 11-reductase deficiency, J Endocrinol, 129, 219
Cited by
Items 101–200 of 1,000
Purnell, J. Q., Kahn, S. E., Samuels, M. H., Brandon, D., Loriaux, D. L., & Brunzell, J. D. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90769.2008 · Cited by 112
Role of hormones in sarcopenia
(2021) · Vitamins and Hormones · doi:10.1016/bs.vh.2020.12.021 · Cited by 92
Anagnostis, P. G., Katsiki, N., Adamidou, F., Athyros, V. G., Karagiannis, A. I., Kita, M. D., & Mikhailidis, D. P. (2012) · Metabolism · doi:10.1016/j.metabol.2012.05.002 · Cited by 116
Exploring the pathogenesis of IIH: An inflammatory perspective
Sinclair, A. J., Ball, A. K., Burdon, M., Clarke, C. E., Stewart, P. M., Curnow, J., & Rauz, S. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.029 · Cited by 122
“11β-HSD1 is expressed in a wide variety of tissues but its principle role in humans is mediating local cortisol availability, a potent anti-inflammatory mediator, driving hepatic gluconeogenesis and regulating adipocyte differentiation (Tomlinson et al., 2004).”
Self-citationModulation of glucocorticoid metabolism by the growth hormone – IGF‐1 axis
Agha, A., & Monson, J. P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02763.x · Cited by 108
Staab-Weijnitz, C. A., & Maser, E. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.013 · Cited by 122
Sinclair, A. J., Walker, E. A., Burdon, M. A., van Beek, A. P., Kema, I. P., Hughes, B. A., Murray, P. I., Nightingale, P. G., Stewart, P. M., Rauz, S., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0729 · Cited by 103
Self-citationThe Alliance of Mesenchymal Stem Cells, Bone, and Diabetes
Napoli, N., Strollo, R., Paladini, A., Briganti, S., Pozzilli, P., & Epstein, S. (2014) · International Journal of Endocrinology · doi:10.1155/2014/690783 · Cited by 110
“PPAR-𝛾2 and aP2, known markers of adipocyte differentiation and maturation, were raised in diabetic NOD mice, together with increased number of adipocytes.”
Hardy, R. S., Filer, A., Cooper, M. S., Parsonage, G., Raza, K., Hardie, D. L., Rabbitt, E. H., Stewart, P. M., Buckley, C. D., & Hewison, M. (2006) · Arthritis Research & Therapy · doi:10.1186/ar1993 · Cited by 98
“(page number not for citation purposes) glucocorticoids is catalyzed by the enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which is located on the luminal surface of the endoplasmic reticulum [5,6].”
Self-citationTherapeutic manipulation of glucocorticoid metabolism in cardiovascular disease
Hadoke, P. W. F., Iqbal, J., & Walker, B. R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00047.x · Cited by 99
“In addition, it is possible that some antiatherosclerotic interventions owe part of their effectiveness to regulation of 11-HSDs as PPAR-a agonists, such as fibrates (which are important agents for treating dyslipidaemia) reduce 11-HSD1 expression and activity in murine liver (Hermanowski-Vosatka et al., 2000).”
InfluentialHughes, K. A., Webster, S. P., & Walker, B. R. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.481 · Cited by 102
“In addition to its expression in liver and adipose tissue, 11 β -HSD1 is active in a number of other cells and tissues [115] .”
Spies, C. M., Strehl, C., van der Goes, M. C., Bijlsma, J. W. J., & Buttgereit, F. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.11.002 · Cited by 113
Drug Insight: selective agonists and antagonists of the glucocorticoid receptor
McMaster, A., & Ray, D. W. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0745 · Cited by 104
Tomlinson, J. W., Sherlock, M., Hughes, B., Hughes, S. V., Kilvington, F., Bartlett, W., Courtney, R., Rejto, P., Carley, W., & Stewart, P. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2325 · Cited by 98
Self-citationAdrenal insufficiency in critical illness
Cooper, M. S., & Stewart, P. M. (2007) · Journal of Intensive Care Medicine · doi:10.1177/0885066607307832 · Cited by 97
Self-citationMcWhinney, B. C., Briscoe, S., Ungerer, J. P. J., & Pretorius, C. J. (2010) · Journal of Chromatography B · doi:10.1016/j.jchromb.2010.08.044 · Cited by 97
Lavery, G. G., Walker, E. A., Turan, N., Rogoff, D., Ryder, J. W., Shelton, J. M., Richardson, J. A., Falciani, F., White, P. C., Stewart, P. M., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710067200 · Cited by 99
Self-citationAdamantyl triazoles as selective inhibitors of 11β-hydroxysteroid dehydrogenase type 1
Olson, S. H., Aster, S. D., Brown, K., Carbin, L., Graham, D. W., Hermanowski‐Vosatka, A., LeGrand, C. B., Mundt, S. S., Robbins, M. A., Schaeffer, J. M., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.06.040 · Cited by 97
Lavery, G. G., Walker, E. A., Tiganescu, A., Ride, J. P., Shackleton, C. H. L., Tomlinson, J. W., Connell, J. M. C., Ray, D. W., Biason-Lauber, A., Malunowicz, E. M., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0743 · Cited by 95
“11-HSD1(encodedbytheHSD11B1gene)isabidirectional enzyme in vitro acting as a reductase (cortisone to cortisol) or as a dehydrogenase (cortisol to cortisone) but in vivo functions primarilyasareductase( 1 ).ItthereforeappearedthatHSD11B1 was the obvious candidate gene mutated in CRD; however, no coding mutations direct…”
InfluentialSelf-citationNeutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib
Kim, S. Y., Jun, H. S., Mead, P., Mansfield, B. C., & CHOU, J. Y. (2008) · Blood · doi:10.1182/blood-2007-12-129114 · Cited by 95
Kratschmar, D. V., Calabrese, D., Walsh, J., Lister, A., Birk, J., Appenzeller-Herzog, C., Moulin, P., Goldring, C. E., & Odermatt, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036774 · Cited by 92
High-resolution daily profiles of tissue adrenal steroids by portable automated collection
Upton, T. J., Zavala, E., Methlie, P., Kämpe, O., Tsagarakis, S., Øksnes, M., Bensing, S., Vassiliadi, D. A., Grytaas, M. A., Botusan, I. R., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg8464 · Cited by 94
“It is well established that glucocorticoid action on target tissues is determined in part by the two isozymes of 11β-hydroxysteroid dehydrogenase (11β-HSD) that catalyze the interconversion of cortisol and cortisone (31).”
Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2
Ma, X., Lian, Q.-Q., Dong, Q., & Ge, R.-S. (2011) · Toxicology · doi:10.1016/j.tox.2011.04.007 · Cited by 94
Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
Imajo, K., Yoneda, M., Kessoku, T., Ogawa, Y., Maeda, S., Sumida, Y., Hyogo, H., Eguchi, Y., Wada, K., & Nakajima, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121833 · Cited by 89
Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence
Pasieka, A., & Rafacho, A. (2016) · Metabolites · doi:10.3390/metabo6030024 · Cited by 90
“11β-HSD1 is expressed in insulin-target tissues including liver, adipose, and muscles as well as modulating the tissue GC availability [50].”
Minireview: Live and Let Die: Molecular Effects of Glucocorticoids on Bone Cells
Hofbauer, L. C., & Rauner, M. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0069 · Cited by 91
Liu, Y., Mladinov, D., Pietrusz, J. L., Usa, K., & Liang, M. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn231 · Cited by 91
Tomlinson, J. W., Finney, J., Hughes, B. A., Hughes, S. V., & Stewart, P. M. (2008) · Diabetes · doi:10.2337/db08-0094 · Cited by 91
Self-citationShah, S., Hermanowski‐Vosatka, A., Gibson, K., Ruck, R. A., Jia, G., Zhang, J. H., Hwang, P. M. T., Ryan, N. W., Langdon, R. B., & Feig, P. U. (2011) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2011.01.009 · Cited by 97
Hammer, F., Subtil, S., Lux, P., Maser-Gluth, C., Stewart, P. M., Allolio, B., & Arlt, W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2386 · Cited by 90
Self-citationRedox Control of Endoplasmic Reticulum Function
Csala, M., Margittai, É., & Bánhegyi, G. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2529 · Cited by 98
Holmes, M. E., Ekkekakis, P., & Eisenmann, J. C. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00680.x · Cited by 86
Maternal epigenetics and fetal and neonatal growth
Kitsiou‐Tzeli, S., & Tzetis, M. (2016) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000305 · Cited by 90
Xiang, J. S., Ipek, M., Suri, V., Massefski, W. W., Pan, N., Ge, Y., Tam, M., Xing, Y., Tobin, J. F., Xu, X., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.03.093 · Cited by 91
Glucocorticoid resistance as a major drive in sepsis pathology
Dendoncker, K., & Libert, C. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2017.04.002 · Cited by 85
“hydroxysteroid dehydrogenase (11β-HSD) regulates the glucocorticoid activity in cells by converting part of the bioactive cortisol back into the inactive precursor cortisone [22].”
Carbonyl reduction pathways in drug metabolism
Malátková, P., & Wsól, V. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.853078 · Cited by 88
“It has also been suggested that 11b-HSD1 functions as a bidirectional enzyme in vitro, while its main activity in vivo is reduction (Tomlinson et al., 2004).”
11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease
Anderson, A., & Walker, B. R. (2013) · Drugs · doi:10.1007/s40265-013-0112-5 · Cited by 90
“Type 1 (11b-HSD1) on the other hand promotes both the reduction of cortisone to cortisol as well as the reverse oxidation reaction [3, 4].”
Calcaterra, V., Regalbuto, C., Porri, D., Pelizzo, G., Mazzon, E., Vinci, F., Zuccotti, G., Fabiano, V., & Cena, H. (2020) · Biomolecules · doi:10.3390/biom10091324 · Cited by 90
Aldosterone synthesis in the brain contributes to Dahl salt‐sensitive rat hypertension
Gomez‐Sanchez, E. P., Gomez‐Sanchez, C. M., Plonczynski, M., & Gomez‐Sanchez, C. E. (2010) · Experimental Physiology · doi:10.1113/expphysiol.2009.048900 · Cited by 84
Berthiaume, M., Laplante, M., Festuccia, W., Gélinas, Y., Poulin, S., Lalonde, J., Joanisse, D. R., Thieringer, R., & Deshaies, Y. (2007) · Endocrinology · doi:10.1210/en.2006-1199 · Cited by 82
Gettler, L. T., Mcdade, T. W., & Kuzawa, C. W. (2011) · American Journal of Human Biology · doi:10.1002/ajhb.21187 · Cited by 81
Chronic social stress, hedonism and vulnerability to obesity: Lessons from Rodents
Coccurello, R., D'Amato, F. R., & Moles, A. (2008) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.05.018 · Cited by 91
Non-genomic effect of glucocorticoids on cardiovascular system
Lee, S. R., Kim, H. K., Youm, J. B., Dizon, L. A., Song, I. S., Jeong, S. H., Seo, D. Y., Ko, K. S., Rhee, B. D., Kim, N., et al. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-012-1155-2 · Cited by 90
“The local state of 11β-HSD2, therefore, plays a role in the regulation of tissue sensitivity to GCs [54, 114].”
Charmandari, E., Kino, T., & Chrousos, G. P. (2013) · Endocrine Development · doi:10.1159/000342505 · Cited by 81
“This variable clinical phenotype is due to variations in the tissue sensitivity of the glucocorticoid, mineralocorticoid and/ or androgen receptor signaling pathways, variations in the activity of key hormoneinactivating or - activating enzymes, such as the 11β-hydroxysteroid dehydrogenase [25] and other genetic or ep…”
Tarantino, G. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i40.6735 · Cited by 82
Disruption of glucocorticoid action by environmental chemicals: Potential mechanisms and relevance
Odermatt, A., Gumy, C., Atanasov, A. G., & Dzyakanchuk, A. A. (2006) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.09.010 · Cited by 88
Gender-Specific Differences in Skeletal Muscle 11β-HSD1 Expression Across Healthy Aging
Hassan-Smith, Z. K., Morgan, S. A., Sherlock, M., Hughes, B., Taylor, A. E., Lavery, G. G., Tomlinson, J. W., & Stewart, P. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1516 · Cited by 77
Self-citationRohde, J. J., Pliushchev, M. A., Sorensen, B. K., Wódka, D., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Pan, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609364 · Cited by 85
Antenatal Dexamethasone Treatment Leads to Changes in Gene Expression in a Murine Late Placenta
Baisden, B. L., Sonne, S., Joshi, R., Ganapathy, V., & Shekhawat, P. (2007) · Placenta · doi:10.1016/j.placenta.2007.04.002 · Cited by 79
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN
Piguet, A.-C., Stroka, D., Zimmermann, A., & Dufour, J.-F. (2010) · Clinical Science · doi:10.1042/cs20090313 · Cited by 79
Sher, L. B., Harrison, J. R., Adams, D. J., & Kream, B. E. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0297-z · Cited by 80
Role of fetal membranes in signaling of fetal maturation and parturition
Myatt, L., & Sun, K. (2009) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082771lm · Cited by 80
Adipose tissue 11β-hydroxysteroid dehydrogenase type 1 expression in obesity and Cushing’s syndrome
Mariniello, B., Ronconi, V., Rilli, S., Bernante, P., Boscaro, M., Mantero, F., & Giacchetti, G. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02228 · Cited by 74
“11b-Hydrxysteroid dehydrogenase type 2 (11b-HSD2) is a NAD(H)dependent dehydrogenase, which converts F to E protecting illicit occupation of mineralocorticoid receptor by F in aldosterone target tissues ( 4 ).”
Sex differences in 11-oxygenated androgen patterns across adulthood
Davio, A., Woolcock, H., Nanba, A. T., Rege, J., O’Day, P., Ren, J., Zhao, L., Ebina, H., Auchus, R., Rainey, W. E., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa343 · Cited by 76
Kang, S., Tsai, L. T., Zhou, Y., Evertts, A., Xu, S., Griffin, M. J., Issner, R., Whitton, H. J., Garcia, B. A., Epstein, C. B., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3080 · Cited by 77
Gambineri, A., Vicennati, V., Genghini, S., Tomassoni, F., Pagotto, U., Pasquali, R., & Walker, B. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2222 · Cited by 75
Peng, C.-C., Templeton, I. E., Thummel, K. E., Davis, C. N., Kunze, K. L., & Isoherranen, N. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.53 · Cited by 81
Adiposopathy: why do adiposity and obesity cause metabolic disease?
Bays, H., & Ballantyne, C. (2006) · Future Lipidology · doi:10.2217/17460875.1.4.389 · Cited by 74
Garbrecht, M. R., Klein, J. M., Schmidt, T. J., & Snyder, J. M. (2006) · Neonatology · doi:10.1159/000088653 · Cited by 72
“HSD1 utilizes nicotinamide adenine dinucleotide phosphate (NADPH) as a cofactor in the 11β-oxidoreduction of inactive cortisone to active cortisol [”
Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity
Pasquali, R., Vicennati, V, Gambineri, A., & Pagotto, U. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.129 · Cited by 74
Liu, T., Wang, J., Tong, Y., Wu, L., Xie, Y., He, P., Lin, S., & Hu, X. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-023-04840-x · Cited by 80
“Conversely, overexpression of HSD11B1 (corticosteroid 11-beta-dehydrogenase isozyme 1), which catalyzes the conversion of the active form of cortisol [74], has been found to result in visceral obesity, insulin-resistant diabetes, and dyslipidemia [75].”
Systematic review of surgical treatment of subclinical Cushing's syndrome
Iacobone, M., Citton, M., Scarpa, M., Viel, G., Boscaro, M., & Nitti, D. (2015) · British Journal of Surgery · doi:10.1002/bjs.9742 · Cited by 72
Depot‐specific Regulation of the Conversion of Cortisone to Cortisol in Human Adipose Tissue
Lee, M., Fried, S. K., Mundt, S. S., Wang, Y., Sullivan, S., Stefanni, A., Daugherty, B. L., & Hermanowski‐Vosatka, A. (2008) · Obesity · doi:10.1038/oby.2008.207 · Cited by 73
Ribas, L., Vanezis, K., Imués-Figueroa, M. A., & Piferrer, F. (2017) · Epigenetics & Chromatin · doi:10.1186/s13072-017-0168-7 · Cited by 77
Glucocorticoid Modulation of Insulin Signaling in Human Subcutaneous Adipose Tissue
Gathercole, L. L., Bujalska, I. J., Stewart, P. M., & Tomlinson, J. W. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1399 · Cited by 73
“In adipose, liver and to a lesser extent in muscle, the type 1 isoform predominates, converting inactive cortisone to active cortisol thus amplifying local GC effects (46).”
Self-citationMechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review
Chiodini, I., Vainicher, C. E., Morelli, V, Palmieri, S., Cairoli, E., Salcuni, A. S., Copetti, M., & Scillitani, A. (2016) · European Journal of Endocrinology · doi:10.1530/eje-16-0289 · Cited by 73
11β-hydroxysteroid dehydrogenases: A growing multi-tasking family
Gómez-Sánchez, E. P., & Gómez-Sánchez, C. E. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111210 · Cited by 89
Lavery, G. G., Zielinska, A. E., Gathercole, L. L., Hughes, B., Semjonous, N., Guest, P., Saqib, K., Sherlock, M., Reynolds, G., Morgan, S. A., et al. (2012) · Endocrinology · doi:10.1210/en.2012-1019 · Cited by 69
Self-citationTomlinson, J., & Stewart, P. M. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0023 · Cited by 82
“) 11β-HSD1 can also act as a dehydrogenase, inactivating cortisol to cortisone, and it is this 'setpoint' between inactivation and activation that is likely to be pivotal in terms of its clinical action”
Self-citationFreeman, L., Hewison, M., Hughes, S. V., Evans, K. N., Hardie, D., Means, T. K., & Chakraverty, R. (2005) · Blood · doi:10.1182/blood-2005-01-0186 · Cited by 71
Self-citationInfluence of glucocorticoids and growth hormone on insulin sensitivity in humans
Yuen, K. C. J., Chong, L. E., & Riddle, M. (2013) · Diabetic Medicine · doi:10.1111/dme.12184 · Cited by 84
Crosstalk between TNF and glucocorticoid receptor signaling pathways
Bogaert, T. V., Bosscher, K. D., & Libert, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.04.003 · Cited by 80
Chen, J., Fan, F., Qu, G., Tang, J., Xi, Y., Bi, C., Sun, Z., & Zhang, X. (2019) · Metabolic Engineering · doi:10.1016/j.ymben.2019.10.006 · Cited by 72
Skeletal Diseases in Cushing’s Syndrome: Osteoporosis versus Arthropathy
Kaltsas, G., & Makras, P. (2010) · Neuroendocrinology · doi:10.1159/000314298 · Cited by 71
Glucocorticoids: Fuelling the Fire of Atherosclerosis or Therapeutic Extinguishers?
MacLeod, C., Hadoke, P. W. F., & Nixon, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147622 · Cited by 72
Yang, Z., Guo, C., Zhu, P., Li, W., Myatt, L., & Sun, K. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0303 · Cited by 71
Baudrand, R. F., Carvajal, C. A., Riquelme, A. J., Morales, M., Solís, N., Pizarro, M., Escalona, A., Boza, C., Pérez, G., Domínguez, A., et al. (2009) · Obesity Surgery · doi:10.1007/s11695-009-9937-0 · Cited by 81
DHEA Induces 11β-HSD2 by Acting on CCAAT/Enhancer-Binding Proteins
Balazs, Z., Schweizer, R. A. S., Frey, F. J., Rohner-Jeanrenaud, F. C., & Odermatt, A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007030263 · Cited by 72
Gomez-Sanchez, E. P., Romero, D. G., de Rodriguez, A. F., Warden, M. P., Krozowski, Z., & Gomez-Sanchez, C. E. (2008) · Endocrinology · doi:10.1210/en.2007-0328 · Cited by 66
Stegk, J. P., Ebert, B., Martin, H.-J., & Maser, E. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.10.030 · Cited by 78
McMaster, A., & Ray, D. W. (2007) · Experimental Physiology · doi:10.1113/expphysiol.2006.036194 · Cited by 82
“This enzyme is predominantly expressed in liver and adipose tissue and so acts not only to increase the circulating concentration of active glucocorticoid but can also act in a tissue-specific manner to amplify glucocorticoid action (Stewart, 2003; Tomlinson et al. 2004; Seckl, 2004; Kershaw et al. 2005).”
Pofi, R., & Tomlinson, J. (2019) · Obstetric Medicine · doi:10.1177/1753495x19847832 · Cited by 76
Self-citationFetal origins of insulin resistance and the metabolic syndrome: A key role for adipose tissue?
Meas, T. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.09.001 · Cited by 82
Obesity in the pathogenesis of type 2 diabetes
Day, C., & Bailey, C. J. (2011) · The British Journal of Diabetes · doi:10.1177/1474651411407418 · Cited by 86
Molusky, M. M., Li, S., Ma, D., Yu, L., & Lin, J. D. (2012) · Diabetes · doi:10.2337/db11-0970 · Cited by 65
“In humans, glucococorticoids circulate as protein-bound inactive precursor (cortisone) that can be converted into active hormone (cortisol) in tissues by 11b-hydroxysteroid dehydrogenase 1 (HSD11b1 or HSD1), an endoplasmic reticulum membrane protein (9,10).”
McNelis, J. C., Manolopoulos, K. N., Gathercole, L. L., Bujalska, I. J., Stewart, P. M., Tomlinson, J. W., & Arlt, W. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2012 · Cited by 66
Self-citationSensitivity of bone to glucocorticoids
COOPER, M. S. (2004) · Clinical Science · doi:10.1042/cs20040070 · Cited by 67
Self-citationHu, G., Lin, H., Lian, Q., Zhou, S., Guo, J., Zhou, H.-Y., Chu, Y., & Ge, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0049976 · Cited by 78
Local glucocorticoid production in the mouse lung is induced by immune cell stimulation
Hostettler, N., Bianchi, P., Gennari‐Moser, C., Kassahn, D., Schoonjans, K., Corazza, N., & Brunner, T. (2012) · Allergy · doi:10.1111/j.1398-9995.2011.02749.x · Cited by 65
Why is 11β-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen?
Odermatt, A., Atanasov, A. G., Balázs, Z., Schweizer, R. A. S., Nashev, L. G., Schuster, D., & Langer, T. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.040 · Cited by 83
Goedecke, J. H., Wake, D. J., Levitt, N. S., Lambert, E. V., Collins, M. R., Morton, N. M., Andrew, R., Seckl, J. R., & Walker, B. R. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02552.x · Cited by 67
Stimson, R. H., Andrew, R., McAvoy, N. C., Tripathi, D., Hayes, P. C., & Walker, B. R. (2011) · Diabetes · doi:10.2337/db10-0726 · Cited by 67
Synthesis of glycyrrhetinic acid derivatives for the treatment of metabolic diseases
Beseda, I., Czollner, L., Shah, P., Khunt, R. C., Gaware, R., Kosma, P., Stanetty, C., Ruiz-Ruiz, M. C. D., Amer, H., Mereiter, K., et al. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.036 · Cited by 73
DIAGNOSIS OF ENDOCRINE DISEASE: Evaluation of bone fragility in endocrine disorders
Eller-Vainicher, C., Falchetti, A., Gennari, L., Cairoli, E., Bertoldo, F., Vescini, F., Scillitani, A., & Chiodini, I. (2019) · European Journal of Endocrinology · doi:10.1530/eje-18-0991 · Cited by 69
Glucocorticoid Sensitivity in Young Healthy Individuals:in Vitro and in Vivo Studies
Chriguer, R. S., Elias, L. L. K., da Silva, I. M., Vieira, J. G. H., Moreira, A. C., & de Castro, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0067 · Cited by 68
Paulukinas, R. D., Mesaros, C. A., & Penning, T. M. (2022) · Endocrinology · doi:10.1210/endocr/bqac068 · Cited by 63
Benzothiazole derivatives as novel inhibitors of human 11β-hydroxysteroid dehydrogenase type 1
Su, X., Vicker, N., Ganeshapillai, D., Smith, A., Purohit, A., Reed, M. J., & Potter, B. V. L. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.10.022 · Cited by 66
Mukherjee, K., Edgett, B. A., Burrows, H. W., Castro, C., Griffin, J. L., Schwertani, A. G., Gurd, B. J., & Funk, C. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092031 · Cited by 65
San Millán, J. L., Botella-Carretero, J. I., Álvarez-Blasco, F., Luque-Ramírez, M., Sancho, J., Moghetti, P., & Escobar-Morreale, H. F. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1523 · Cited by 65
Wan, Z., Chenail, E., Xiang, J. S., Li, H., Ipek, M., Bard, J., Svenson, K., Mansour, T. S., Xu, X., Tian, X., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900639u · Cited by 69
Metadata
- Authors
- Tomlinson, J. W., Walker, E. A., Bujalska, I. J., Draper, N., Lavery, G. G., Cooper, M. S., Hewison, M., & Stewart, P. M.
- Affiliations
- Queen Elizabeth Hospital Birmingham (GB)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-10-01
- Volume
- 25
- Issue
- 5
- Pages
- 831-866
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2016125985
- Semantic Scholar
- 7653c899826b606d61172864887c634e9d76851b
- Cited by
- 969
- References
- 412
- Citations by year
- 2026: 17 · 2025: 22 · 2024: 25 · 2023: 23 · 2022: 32 · 2021: 30 · 2020: 27 · 2019: 34 · 2018: 30 · 2017: 33 · 2016: 38 · 2015: 43 · 2014: 55 · 2013: 65 · 2012: 70
- FWCI
- 7.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- 11β-hydroxysteroid dehydrogenase type 1, glucocorticoid metabolism, hexose-6-phosphate dehydrogenase, NADPH cofactor, tissue-specific gene regulation, obesity, metabolic syndrome, glaucoma, osteoporosis, 11β-HSD1 inhibition
- MeSH terms
- Amino Acid Sequence, Animals, Carbohydrate Dehydrogenases, Cloning, Molecular, Cortisone Reductase, Enzyme Inhibitors, Glaucoma, Glucocorticoids, Humans, Hydrocortisone, Molecular Sequence Data, Mutation, NADP, Obesity, Organ Specificity, Osteoporosis, Recombinant Proteins, Substrate Specificity, Transcription, Genetic, Gene Expression Regulation, Enzymologic, Sequence Alignment, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.